Evaluation in a disconnected healthcare system: Problems and suggested solutions from the Australian HTA review

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 10, Issue 6, 2010, Pages 615-617

  Gallego, Gisselle ^a,b   Harris, Anthony ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Australia; health technology assessment; HTA; technologies

Indexed keywords

ADVISORY COMMITTEE; AUSTRALIA; COMMERCIAL PHENOMENA; EDITORIAL; EVALUATION; EVIDENCE BASED PRACTICE; FUNDING; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH TECHNOLOGY ASSESSMENT; RISK BENEFIT ANALYSIS;

AUSTRALIA; BIOMEDICAL TECHNOLOGY; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; PROGRAM DEVELOPMENT; QUALITY OF HEALTH CARE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 78650427998     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.10.74     Document Type: Editorial

References (7)

1. Australian Government Department of Health and Ageing. Review of Health Technology Assessment in Australia. Commonwealth of Australia, Canberra, Australia (2009).
2. Therapeutics Goods Administration. Regulation of Therapeutic Goods in Australia. Australian Goverment Department of Health and Ageing, Canberra, Australia (2005).
3. Salked G, Mitchell A, Hill S. Pharmaceuticals. In: Economics and Australian Health Policy. Mooney G, Scotton R (Eds). Allen & Unwin, Sydney, Australia 115-136 (1999).
4. Australia Productivity Commission. Impacts of Advances in Medical Technology in Australia: Productivity Commission Research Report. Productivity Commission, Melbourne, Australia (2005).
5. The Auditor-General Australian National Audit Office. Audit Report No 12 of 1997-98: Performance Audit, The Pharmaceutical Benefits Scheme. Department of Health and Family Services, Canberra, Australia (1997).
6. Goeree R, Chandra K, Tarride JE et al. Conditionally funded field evaluations: paths coverage with evidence development program for Ontario. Value Health 13, S8-S11 (2010).
7. Harris A, Mortimer D. Funding illness prevention and health promotion in Australia: a way forward. Aust. New Zealand Health Policy, 6, 25 (2009).